Pacira BioSciences, Inc. Balance Sheet
PCRX / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Pacira BioSciences, Inc. had $1.3B in total assets and $693M in shareholders' equity as of FY2025. Total debt was $372M against $159M in cash, resulting in $214M net debt.
Based on SEC 10-K filings.
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $158.5M | $276.8M | $153.3M | $104.1M | $585.6M | $132.5M | $54.1M | $57.0M | $57.0M | $35.9M | $57.0M | $37.5M | $46.2M | $26.1M | $46.2M |
| Accounts Receivable | $124.1M | $113.3M | $105.6M | $98.4M | $96.3M | $53.0M | $47.5M | $38.0M | $31.7M | $29.9M | $25.9M | $22.4M | $14.6M | $4.4M | $2.1M |
| Inventory | $152.9M | $125.3M | $104.4M | $96.1M | $98.5M | $64.7M | $58.3M | $48.6M | $41.4M | $31.3M | $61.6M | $29.3M | $15.6M | $12.1M | $1.2M |
| Current Assets | $548.0M | $745.1M | $510.0M | $498.3M | $866.0M | $651.6M | $408.6M | $478.0M | $391.1M | $243.1M | $252.6M | $214.3M | $106.8M | $60.9M | $82.6M |
| PP&E (Net) | $140.7M | $167.2M | $173.9M | $183.5M | $188.4M | $136.7M | $104.7M | $108.7M | $107.0M | $101.0M | $90.3M | $60.6M | $48.2M | $39.1M | $25.1M |
| Goodwill | $20.2M | $0 | $163.2M | $163.2M | $99.5M | $99.5M | $62.0M | $55.2M | $46.7M | $46.7M | $30.9M | $23.8M | $8.0M | $8.0M | $0 |
| Total Assets | $1.3B | $1.6B | $1.6B | $1.7B | $2.1B | $1.3B | $831.1M | $689.4M | $628.4M | $391.5M | $387.7M | $326.1M | $169.8M | $112.1M | $113.5M |
| Current Liabilities | $120.6M | $309.9M | $97.4M | $147.8M | $521.1M | $253.3M | $107.7M | $60.7M | $56.2M | $44.8M | $149.8M | $140.0M | $121.9M | $14.2M | $31.9M |
| Total Debt | $372.2M | $585.3M | $522.4M | $689.5M | - | - | - | - | - | $108.7M | $104.0M | $103.1M | $99.0M | $25.2M | $25.6M |
| Shareholders' Equity | $693.1M | $778.3M | $870.1M | $775.0M | $354.9M | $321.2M | $279.5M | $219.0M | $218.4M | $219.0M | $218.4M | $171.1M | $48.3M | -$48.4M | $48.3M |